Exxon Mobil: Normalization In The Middle East Is Welcomed, Watch Q2 Production (NYSE:XOM) | Seeking Alpha
HomeStock IdeasLong IdeasEnergy AnalysisSummaryExxon Mobil maintains a "Buy" rating with a $170 price target, supported by strong profitability and cash flow despite recent oil price declines. Q1 results. . .
HomeStock IdeasLong IdeasEnergy AnalysisSummaryExxon Mobil maintains a "Buy" rating with a $170 price target, supported by strong profitability and cash flow despite recent oil price declines. Q1 results showed resilient operational execution, with $4. 2 billion in GAAP earnings, $8. 7 billion in cash flow from operations, and disciplined capex at $6. 2 billion. XOM’s valuation remains attractive with a low PEG ratio and a 17x P/E multiple, though EPS estimates may normalize as oil prices stabilize. Technicals are mixed; shares trade near the 200-day moving average, with $145 as key resistance and $120 as support heading into Q2 earnings. JHVEPhoto/iStock Editorial via Getty ImagesOil prices have cratered from peaks near $120 for WTI and Brent. So too have energy equities. Shares of Exxon Mobil Corporation (XOM) reached a high above $176 in late March, back when dated, prompt, and out-month Brent futures contracts were very elevated. Today, “Texas9. 43K FollowersAnalyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure:Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.